Cargando…
Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet
The process of understanding the control and capability (PUCC) is an iterative closed loop process for continuous improvement. It covers the DMAIC toolkit in its three phases. PUCC is an iterative approach that rotates between the three pillars of the process of understanding, process control, and p...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094555/ https://www.ncbi.nlm.nih.gov/pubmed/21607050 http://dx.doi.org/10.4103/0975-1483.76415 |
_version_ | 1782203580857450496 |
---|---|
author | Chabukswar, AR Jagdale, SC Kuchekar, BS Joshi, VD Deshmukh, GR Kothawade, HS Kuckekar, AB Lokhande, PD |
author_facet | Chabukswar, AR Jagdale, SC Kuchekar, BS Joshi, VD Deshmukh, GR Kothawade, HS Kuckekar, AB Lokhande, PD |
author_sort | Chabukswar, AR |
collection | PubMed |
description | The process of understanding the control and capability (PUCC) is an iterative closed loop process for continuous improvement. It covers the DMAIC toolkit in its three phases. PUCC is an iterative approach that rotates between the three pillars of the process of understanding, process control, and process capability, with each iteration resulting in a more capable and robust process. It is rightly said that being at the top is a marathon and not a sprint. The objective of the six sigma study of Ranitidine hydrochloride tablets is to achieve perfection in tablet manufacturing by reviewing the present robust manufacturing process, to find out ways to improve and modify the process, which will yield tablets that are defect-free and will give more customer satisfaction. The application of six sigma led to an improved process capability, due to the improved sigma level of the process from 1.5 to 4, a higher yield, due to reduced variation and reduction of thick tablets, reduction in packing line stoppages, reduction in re-work by 50%, a more standardized process, with smooth flow and change in coating suspension reconstitution level (8%w/w), a huge cost reduction of approximately Rs.90 to 95 lakhs per annum, an improved overall efficiency by 30% approximately, and improved overall quality of the product. |
format | Text |
id | pubmed-3094555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-30945552011-05-23 Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet Chabukswar, AR Jagdale, SC Kuchekar, BS Joshi, VD Deshmukh, GR Kothawade, HS Kuckekar, AB Lokhande, PD J Young Pharm Pharmaceutics The process of understanding the control and capability (PUCC) is an iterative closed loop process for continuous improvement. It covers the DMAIC toolkit in its three phases. PUCC is an iterative approach that rotates between the three pillars of the process of understanding, process control, and process capability, with each iteration resulting in a more capable and robust process. It is rightly said that being at the top is a marathon and not a sprint. The objective of the six sigma study of Ranitidine hydrochloride tablets is to achieve perfection in tablet manufacturing by reviewing the present robust manufacturing process, to find out ways to improve and modify the process, which will yield tablets that are defect-free and will give more customer satisfaction. The application of six sigma led to an improved process capability, due to the improved sigma level of the process from 1.5 to 4, a higher yield, due to reduced variation and reduction of thick tablets, reduction in packing line stoppages, reduction in re-work by 50%, a more standardized process, with smooth flow and change in coating suspension reconstitution level (8%w/w), a huge cost reduction of approximately Rs.90 to 95 lakhs per annum, an improved overall efficiency by 30% approximately, and improved overall quality of the product. Medknow Publications 2011 /pmc/articles/PMC3094555/ /pubmed/21607050 http://dx.doi.org/10.4103/0975-1483.76415 Text en © Journal of Young Pharmacists http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Pharmaceutics Chabukswar, AR Jagdale, SC Kuchekar, BS Joshi, VD Deshmukh, GR Kothawade, HS Kuckekar, AB Lokhande, PD Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet |
title | Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet |
title_full | Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet |
title_fullStr | Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet |
title_full_unstemmed | Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet |
title_short | Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet |
title_sort | six sigma: process of understanding the control and capability of ranitidine hydrochloride tablet |
topic | Pharmaceutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094555/ https://www.ncbi.nlm.nih.gov/pubmed/21607050 http://dx.doi.org/10.4103/0975-1483.76415 |
work_keys_str_mv | AT chabukswarar sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet AT jagdalesc sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet AT kuchekarbs sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet AT joshivd sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet AT deshmukhgr sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet AT kothawadehs sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet AT kuckekarab sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet AT lokhandepd sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet |